Literature DB >> 7880841

Mutagenesis of the H-ras p21 at glycine-60 residue disrupts GTP-induced conformational change.

Y J Sung1, M Carter, J M Zhong, Y W Hwang.   

Abstract

The function of Gly-60, the conserved glycine in the DXXG domain of v-H-ras, was examined by site-directed mutagenesis. It was found that while the G60A (Gly-60 to Ala substitution) mutation has little effect on the interaction of H-ras with guanine nucleotides, it completely abolishes the biological activity of v-H-ras. The G60A mutation also exerts little effect on the interaction of H-ras with SDC25C (a guanine nucleotide exchange factor) and GAP. However, the G60A mutation does lower the ability of H-ras to bind Raf. GTP induces an enhancement of fluorescence emission in complexes consisting of H-ras and the fluorescent dye 8-anilino-1-naphthalenesulfonic acid. This enhancement is blocked by the G60A mutation. On the basis of these observations, we propose that the GTP-induced conformational change of H-ras, a process required for H-ras activities, is impaired by the G60A mutation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7880841     DOI: 10.1021/bi00010a040

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Relation between the conformational heterogeneity and reaction cycle of Ras: molecular simulation of Ras.

Authors:  Chigusa Kobayashi; Shinji Saito
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

2.  Restricting conformational flexibility of the switch II region creates a dominant-inhibitory phenotype in Obg GTPase Nog1.

Authors:  Yevgeniya R Lapik; Julia M Misra; Lester F Lau; Dimitri G Pestov
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

3.  Characterization of a Ras mutant with identical GDP- and GTP-bound structures .

Authors:  Bradley Ford; Sean Boykevisch; Chen Zhao; Simone Kunzelmann; Dafna Bar-Sagi; Christian Herrmann; Nicolas Nassar
Journal:  Biochemistry       Date:  2009-12-08       Impact factor: 3.162

Review 4.  Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.

Authors:  Jonathan M L Ostrem; Kevan M Shokat
Journal:  Nat Rev Drug Discov       Date:  2016-07-29       Impact factor: 84.694

5.  Mutational analysis of Raf-1 cysteine rich domain: requirement for a cluster of basic aminoacids for interaction with phosphatidylserine.

Authors:  T Improta-Brears; S Ghosh; R M Bell
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

6.  Aspartate-107 and leucine-109 facilitate efficient coupling of glutamine hydrolysis to CTP synthesis by Escherichia coli CTP synthase.

Authors:  Akshai Iyengar; Stephen L Bearne
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

7.  Intragenic suppressor mutations restore GTPase and translation functions of a eukaryotic initiation factor 5B switch II mutant.

Authors:  Byung-Sik Shin; Michael G Acker; David Maag; Joo-Ran Kim; Jon R Lorsch; Thomas E Dever
Journal:  Mol Cell Biol       Date:  2006-12-22       Impact factor: 4.272

8.  Role of the switch II region in the conformational transition of activation of Ha-ras-p21.

Authors:  J F Díaz; M M Escalona; S Kuppens; Y Engelborghs
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

9.  An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.

Authors:  Karen W Gripp; Katia Sol-Church; Patroula Smpokou; Gail E Graham; David A Stevenson; Heather Hanson; David H Viskochil; Laura C Baker; Bridget Russo; Nick Gardner; Deborah L Stabley; Verena Kolbe; Georg Rosenberger
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

10.  K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.

Authors:  Jonathan M Ostrem; Ulf Peters; Martin L Sos; James A Wells; Kevan M Shokat
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.